» Articles » PMID: 36812240

Concordance Between Substance Use Self-report and Hair Analysis in Community-based Adolescents

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 2023 Feb 22
PMID 36812240
Authors
Affiliations
Soon will be listed here.
Abstract

Accurate drug use identification through subjective self-report and toxicological biosample (hair) analysis are necessary to determine substance use sequelae in youth. Yet consistency between self-reported substance use and robust, toxicological analysis in a large sample of youth is understudied. We aim to assess concordance between self-reported substance use and hair toxicological analysis in community-based adolescents. Hair results by LC-MS/MS and GC-MS/MS and self-reported past-year substance use from an Adolescent Brain Cognitive Development (ABCD) Study subsample ( = 1,390; ages 9-13; 48% female) were compared. The participants were selected for hair selection through two methods: high scores on a substance risk algorithm selected 93%; 7% were low-risk, randomly selected participants. Kappa coefficients the examined concordance between self-report and hair results. 10% of youth self-reported any past-year substance use (e.g. alcohol, cannabis, nicotine, and opiates), while a mostly non-overlapping 10% had hair results indicating recent substance use (cannabis, alcohol, non-prescription amphetamines, cocaine, nicotine, opiates, and fentanyl). In randomly selected low-risk cases, 7% were confirmed positive in hair. Combining methods, 19% of the sample self-reported substance use and/or had a positive hair sample. Kappa coefficient of concordance between self-report and hair results was low (kappa = 0.07;  = .007). Hair toxicology identified substance use in high-risk and low-risk ABCD cohort subsamples. Given low concordance between hair results and self-report, reliance on either method alone would incorrectly categorize 9% as non-users. Multiple methods for characterizing substance use history in youth improves accuracy. Larger representative samples are needed to assess the prevalence of substance use in youth.

Citing Articles

The Role of Family Functioning in the Prevention of Depressive Symptoms and Drug Use Among Hispanic Youth.

Graefe B, Lovan P, Lozano A, Estrada Y, Prado G Am J Health Educ. 2024; 55(6):421-430.

PMID: 39619735 PMC: 11606532. DOI: 10.1080/19325037.2024.2338439.


Amygdala volume and depression symptoms in young adolescents who use cannabis.

Wallace A, Huestis M, Sullivan R, Wade N Behav Brain Res. 2024; 472:115150.

PMID: 39009188 PMC: 11656890. DOI: 10.1016/j.bbr.2024.115150.


A Comparison of Remote Versus in-Person Assessments of Substance Use and Related Constructs Among Adolescents.

Wade N, Patel H, Pelham 3rd W Subst Use Misuse. 2024; 59(10):1447-1454.

PMID: 38803212 PMC: 11247956. DOI: 10.1080/10826084.2024.2352108.


Cannabis use and neurocognitive performance at 13-14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study.

Wade N, Wallace A, Huestis M, Lisdahl K, Sullivan R, Tapert S Addict Behav. 2023; 150:107930.

PMID: 38091780 PMC: 10829878. DOI: 10.1016/j.addbeh.2023.107930.


Trends in reported and biologically confirmed drug use among people who use ecstasy in the nightclub/festival-attending population, 2016-2022.

Palamar J, Salomone A, Massano M, Cleland C Drug Alcohol Depend Rep. 2023; 9:100198.

PMID: 38023341 PMC: 10665664. DOI: 10.1016/j.dadr.2023.100198.


References
1.
Volkow N, Koob G, Croyle R, Bianchi D, Gordon J, Koroshetz W . The conception of the ABCD study: From substance use to a broad NIH collaboration. Dev Cogn Neurosci. 2017; 32:4-7. PMC: 5893417. DOI: 10.1016/j.dcn.2017.10.002. View

2.
Wade N, Tapert S, Lisdahl K, Huestis M, Haist F . Substance use onset in high-risk 9-13 year-olds in the ABCD study. Neurotoxicol Teratol. 2022; 91:107090. PMC: 9623820. DOI: 10.1016/j.ntt.2022.107090. View

3.
Luciana M, Bjork J, Nagel B, Barch D, Gonzalez R, Nixon S . Adolescent neurocognitive development and impacts of substance use: Overview of the adolescent brain cognitive development (ABCD) baseline neurocognition battery. Dev Cogn Neurosci. 2018; 32:67-79. PMC: 6039970. DOI: 10.1016/j.dcn.2018.02.006. View

4.
Simmons C, Conley M, Gee D, Baskin-Sommers A, Barch D, Hoffman E . Responsible Use of Open-Access Developmental Data: The Adolescent Brain Cognitive Development (ABCD) Study. Psychol Sci. 2021; 32(6):866-870. PMC: 8726588. DOI: 10.1177/09567976211003564. View

5.
Karoly H, Ross J, Ellingson J, Feldstein Ewing S . Exploring Cannabis and Alcohol Co-Use in Adolescents: A Narrative Review of the Evidence. J Dual Diagn. 2019; 16(1):58-74. PMC: 7007306. DOI: 10.1080/15504263.2019.1660020. View